Skip to content
★ Sign in to follow
MD

Mark D. Booth

Executive
Orexigen Therapeutics, Inc.
Total declarations
15
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (8 ops.)
€1.3M

Latest filing published 02 Mar 2015 for Orexigen Therapeutics, Inc., €73k.

Insider track record

Disclosed buys
0
Disclosed sells
8
Signal history

No signal scores available.

Mark D. Booth: trading record in brief

Mark D. Booth is a declared insider of Orexigen Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 28 June 2012 to 26 February 2015, the count stands at 15 filings.

No open-market purchase appears, only 8 sales worth €1.3M. The rest of the record consists of 2 share grants and 5 option exercises. In 2015 alone, the filings show no purchases and 1 sale.

The newest entry dates from 2 March 2015: an option exercise of €73k, in Orexigen Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Mark D. Booth

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total

15 of 15 declarations